Evaluation and comparison of urinary pyridinium crosslinks in two rat models of bone loss--ovariectomy and adjuvant polyarthritis--using a new automated HPLC method.
A specific HPLC system was developed to assess urinary excretion of collagen crosslinks (pyridinoline (Pyr) and deoxypyridinoline (D.Pyr)) in two models of osteopenia in rats, ovariectomy and adjuvant polyarthritis. The sensitivity of this method was in the picomolar range. In ovariectomized rats, a specific model of bone resorption, Pyr and D.Pyr levels rose early, reaching a peak 2 weeks after surgery. Both levels remained raised during the whole observation period (6 weeks) with no change in the Pyr/D.Pyr ratio. So, in this high bone turnover model, hyperresorption is reflected by the parallel increase of both crosslinks resulting in a significant decrease of bone mineral density (BMD) at 6 weeks (-7.3% vs. control). In polyarthritic rats, in the 2 post-adjuvant weeks, Pyr levels increased in parallel with inflammatory parameters, whereas D.Pyr levels remained unchanged. This is in agreement with our previous report that at the end of the 2nd week after adjuvant there is no change in bone resorption. From the 3rd week, both Pyr and D.Pyr increased. The Pyr/D.Pyr ratio was always significantly higher in polyarthritic rats. These results suggest that the early increase of Pyr level reflects non-osseous collagen breakdown and that bone resorption occurs at a later stage when D.Pyr rises, leading to a dramatic decrease of BMD at 4 weeks (-17.7% vs. control). Taken together, our results suggest that in rat as in human, urinary Pyr is a marker of bone and cartilage breakdown, whereas D.Pyr is a specific marker of bone loss. This automated method described may constitute a very useful tool to evaluate bone and/or cartilage breakdown in rats and for the assessment of protective treatments.
Tordjman
C
C
Division de Rhumatologie, Institut de Recherches Servier, Suresnes, France.
Lhumeau
A
A
Pastoureau
P
P
Meunier
F
F
Serkiz
B
B
Volland
J P
JP
Bonnet
J
J
D000596:Amino Acids / Q000652:urine*; D000818:Animals; D001169:Arthritis, Experimental / Q000652:urine*; D015519:Bone Density / Q000502:physiology; D001851:Bone Diseases, Metabolic / Q000652:urine; D001862:Bone Resorption / Q000652:urine; D002851:Chromatography, High Pressure Liquid; D003094:Collagen / Q000737:chemistry; D003432:Cross-Linking Reagents; D003720:Densitometry; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000652:urine*; D010052:Ovariectomy; D051381:Rats; D017207:Rats, Sprague-Dawley; D012015:Reference Standards
D000596:Amino Acids; D003432:Cross-Linking Reagents; C015484:pyridinoline; C036020:deoxypyridinoline; D003094:Collagen